This post was originally published on this site
https://i-invdn-com.akamaized.net/news/LYNXNPEC0Q0MJ_M.jpg
Incyte announced earnings per share of $1.24 on revenue of $688M. Analysts polled by Investing.com anticipated EPS of $0.5 on revenue of $608.61M.
Incyte shares are up 16.57% from the beginning of the year , still down 7.73% from its 52 week high of $110.32 set on July 7. They are under-performing the Nasdaq 100 which is up 26.59% from the start of the year.
Incyte’s report follows an earnings beat by J&J on July 16, who reported EPS of $1.67 on revenue of $18.34B, compared to forecasts EPS of $1.49 on revenue of $17.61B.
Roche Holding ADR had beat expectations on July 23 with second quarter EPS of $1.45 on revenue of $15.27B, compared to forecast for EPS of $1.42 on revenue of $15.43B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
